Endostatin therapy reveals a U-shaped curve for antitumor activity

Vascular Biology Program, Department of Surgery, Children's Hospital Boston, Harvard Medical School, Boston, MA 02115, USA.
Cancer Gene Therapy (Impact Factor: 2.42). 07/2006; 13(6):619-27. DOI: 10.1038/sj.cgt.7700938
Source: PubMed


Developing continuous systemic delivery of endostatin has been a goal of many laboratories. We have employed a method of gene therapy utilizing different viral constructs. Here, we report that a new serotype of adeno-associated viruses, which incorporates canine endostatin, provides dose-dependent transgene expression in the circulation after intramuscular injection in mice. Elevated levels of endostatin remained stable in the circulation for at least 4 months. In vitro assays determined that the protein expressed was biologically active. Antitumor activities of the above construct demonstrated a U-shape curve, where the maximum activity was observed within a certain critical concentration range. These data suggest that an optimum dose range may be required to achieve therapeutic efficacy in large animal models.

Download full-text


Available from: David Zurakowski, May 19, 2014
15 Reads
  • Source
    • "Interestingly, endostatin has a tumour-specific optimal inhibition concentration, higher and lower dosages having less inhibitory effect (Celik et al, 2005; Tjin Tham Sjin et al, 2006). All in all, endostatin is associated with several fundamental aspects of cancer including tumour cell differentiation, cancer angiogenesis and lymphangiogenesis, and inflammatory cell infiltration (Brideau et al, 2007; Seppinen and Pihlajaniemi, 2011). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Background: Endostatin, a fragment of collagen XVIII, is an endogenous angiogenesis inhibitor with anti-tumour functions. However, elevated circulating endostatin concentrations have been found in several human cancers including colorectal cancer (CRC). Methods: Serum endostatin levels were measured by enzyme-linked immunoassay from a series of 143 patients with CRC and from 84 controls, and correlated with detailed clinicopathological features of CRC, serum leukocyte differential count and C-reactive protein (CRP) levels. Results: Patients with CRC had higher serum endostatin levels than the controls (P=0.005), and high levels associated with age, tumour invasion through the muscularis propria and poor differentiation, but not with metastases. Endostatin levels showed a positive correlation with the markers of systemic inflammatory response and a negative correlation with the densities of tumour-infiltrating mast cells and dendritic cells. Collagen XVIII was expressed in tumour stroma most strikingly in blood vessels and capillaries, and in the muscle layer of the bowel wall. Conclusions: Elevated endostatin levels in CRC correlate with systemic inflammation and invasion through the muscularis propria. Increased endostatin level may be a result of invasion-related cleavage of collagen XVIII expressed in the bowel wall. The negative correlations between serum endostatin and intratumoural mast cells and immature dendritic cells may reflect angiogenesis inhibition by endostatin.
    European Journal of Cancer 08/2014; 111(8). DOI:10.1038/bjc.2014.456 · 5.42 Impact Factor
  • Source
    • "Considering that BPA has been described as a xenoestrogen, it is interesting to note that Vandenberg et al. (2006) found that mice exposed to estradiol exhibited a non monotonic dose response for mammary gland morphology. Other classes of compounds, most notably the angiogenesis inhibitors, have also reported nonmonotonic therapeutic dose responses (Benelli et al. 2003; Bruns et al. 2004; Celik et al. 2005; Humar et al. 2002; Lalani et al. 2004; Motegi et al. 2002; Panigrahy et al. 2002; Slaton et al. 1999; Tjin Tham Sjin et al. 2005, 2006; Trinh et al. 2000; Yamaguchi et al. 1999). Given that our data suggest a potential role for BPA in tumor angiogenesis because of the significant increases in tumor volume and the incidence of metastasis, future research efforts focusing on this connection are warranted. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Bisphenol A (BPA) is a synthetic compound used to produce plastics and epoxy resins. BPA can leach from these products in appreciable amounts, resulting in nearly ubiquitous daily exposure to humans. Whether BPA is harmful to humans, especially when administered orally in concentrations relevant to humans, is a topic of debate. In this study, we investigated the role of chronic oral exposure to BPA during adulthood on mammary carcinogenesis by using a transgenic mouse model that spontaneously develops tumors through overexpression of wild-type erbB2 [mouse mammary tumor virus (MMTV)-erbB2]. MMTV-erbB2 mice were exposed to 0, 2.5, 25, 250, or 2,500 µg BPA/L drinking water from 56 until 112 days of age (for mechanism of action) or 252 days of age (for tumorigenesis). Cellular and molecular mechanisms of BPA action in the mammary gland were investigated via immunohistochemistry and immunoblotting. Only low doses of BPA significantly decreased tumor latency and increased tumor multiplicity, tumor burden, and the incidence of metastasis. All BPA doses significantly increased the cell proliferation index, but only the higher doses also increased the apoptotic index in the mammary gland. At the molecular level, 25 µg BPA/L, but not 2,500 µg BPA/L, increased phosphorylation of erbB2, erbB3, insulin-like growth factor 1 receptor, and Akt in the mammary gland. Low, but not high, BPA doses significantly accelerated mammary tumorigenesis and metastasis in MMTV-erbB2 mice. The combined ratio of cell proliferation and apoptosis indices and alterations in protein expression best predicted the ability of each dose of BPA to alter tumorigenesis in this model.
    Environmental Health Perspectives 11/2011; 119(11):1604-9. DOI:10.1289/ehp.1103850 · 7.98 Impact Factor
  • Source
    • "Nowadays, animal experiments in vivo have been carried out. The clinical evaluation, however, calls for more deep research about the gene transduction system with better efficiency, specificity and safety (Tjin et al, 2006). The comprehensive therapy involving muti-genes transduction can inhibit the tumor in different stages, which may result in more conspicuous curative effect (Liu et al, 2009). "
    [Show abstract] [Hide abstract]
    ABSTRACT: The aim of the present study was to investigate the anti-tumor effect of a pEgr-1-endostatin-TNF-α recombinant plasmid induced by ionizing radiation. Three hundred and twenty mice bearing Lewis lung carcinomas were divided into four experimental groups: blank control, irradiation treatment, plasmid treatment and plasmid combined irradiation treatment. Twenty-four hours after the recombinant plasmid was injected locally into the tumors of the mice, they were irradiated with 10 Gy γ -rays. The concentration of TNF-α and endostatin in the serum of mice was measured by ELISA and tumor growth in each group was compared. The tumor microvessel density was examined by H and E staining and immunohistochemistry analysis of CD31 positive cells. Radiation could induce the expression of pEgr-1-endostatin-TNFα. The levels of endostatin and TNF-α could express steadily for about 4 weeks, with concentrations of 52.6 ± 4.19 and 12.0 ± 0.87 ng/ml respectively, in the second week in combined therapy group and maintained at relative higher level in the fourth week than other groups (F=29.7, P>0.05). Compared with the control group, the tumor micro vessel density was significantly depressed (P>0.05) and tumor growth was significantly inhibited (5907.2 ± 78.6 mm3 vs. 763.5 ± 12.3 mm3, P >0.05). The expression of pEgr-1-endostatin-TNF-α could be induced in mice in vivo and exhibited more significant anti-tumor and anti-angiogenesis effects than irradiation alone.
    Asian Pacific journal of cancer prevention: APJCP 01/2011; 12(11):2933-7. · 2.51 Impact Factor
Show more